Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Preoperative clear carbohydrate drink to improve recovery after elective cesarean under neuraxial anesthesia.

Official title: Evaluation of the Effect of Preoperatively Administered Oral Clear Carbohydrate-Rich Drink on ObsQoR-10 Recovery Scores of Patients Undergoing Elective Cesarean Section With Neuraxial Anesthesia: A Prospective, Randomized, Controlled, Double-Blind Study

Run by Ataturk University · NCT07204795 · Data updated 2026-11-12

This will test whether drinking 400 ml of a clear carbohydrate drink two hours before an elective cesarean under neuraxial anesthesia helps women recover better and feel less hungry, thirsty, or anxious.

More Cesarean Section trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment100 (estimated)
SponsorAtaturk University
Academic / other
Locations1 site (Erzurum)
StatusRecruiting
StartedMay 20, 2025
Main results expectedApril 2026
Study endsMay 2026
Registry record updatedOctober 2, 2025
Trial IDNCT07204795 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Term pregnant women (≥37 weeks) aged 18 or older who are scheduled for elective cesarean under neuraxial anesthesia and who do not have diabetes, significant gastrointestinal disease, obesity, or contraindications to neuraxial anesthesia are ideal candidates.

Probably not a fit

Women with diabetes, obesity, GERD, hiatal hernia, intestinal obstruction, preeclampsia/eclampsia, emergency cesarean, fetal anomalies, or contraindications to neuraxial anesthesia are excluded and unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, double-blind trial enrolling 100 pregnant women scheduled for elective cesarean at Atatürk University Research Hospital. Participants are randomized 1:1 to receive either 400 ml of a carbohydrate-rich clear drink or 400 ml distilled water two hours before surgery, with standardized neuraxial anesthesia and postoperative analgesia. The primary outcome is the ObsQoR-10 score at 24 and 48 hours after surgery, and secondary outcomes include patient-reported hunger, thirst, and anxiety. Randomization is computer-generated and allocation is concealed to investigators and patients to minimize bias.

Why it matters

Potential benefit: If successful, a simple preoperative carbohydrate drink could improve early postpartum recovery and reduce hunger, thirst, and anxiety after elective cesarean.

How similar studies have gone: Preoperative carbohydrate drinks have shown modest benefits for comfort and metabolic markers in other surgical populations, but evidence specific to elective cesarean and ObsQoR-10 outcomes is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age ≥18 years

Scheduled for elective cesarean section under neuraxial anesthesia

Gestational age ≥37 weeks

Exclusion Criteria:

Contraindication to neuraxial anesthesia

Age \<18 years

Refusal to participate in the study

Obesity

Hiatal hernia

Intestinal obstruction

Gastroesophageal reflux disease (GERD)

Diabetes mellitus

Fetal anomalies

Eclampsia or preeclampsia

Substance abuse

Chronic pain conditions

Where it's running

  • Ataturk University Research Hospital
    Erzurum, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.